Literature DB >> 20441681

The evolution of metabolic profiling in parasitology.

E Holmes1.   

Abstract

The uses of metabolic profiling technologies such as mass spectrometry and nuclear magnetic resonance spectroscopy in parasitology have been multi-faceted. Traditional uses of spectroscopic platforms focused on determining the chemical composition of drugs or natural products used for treatment of parasitic infection. A natural progression of the use of these tools led to the generation of chemical profiles of the parasite in in vitro systems, monitoring the response of the parasite to chemotherapeutics, profiling metabolic consequences in the host organism and to deriving host-parasite interactions. With the dawn of the post-genomic era the paradigm in many research areas shifted towards Systems Biology and the integration of biomolecular interactions at the level of the gene, protein and metabolite. Although these technologies have yet to deliver their full potential, metabolic profiling has a key role to play in defining diagnostic or even prognostic metabolic signatures of parasitic infection and in deciphering the molecular mechanisms underpinning the development of parasite-induced pathologies. The strengths and weaknesses of the various spectroscopic technologies and analytical strategies are summarized here with respect to achieving these goals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441681     DOI: 10.1017/S0031182010000260

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  2 in total

Review 1.  How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?

Authors:  Eric Guantai; Kelly Chibale
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

2.  CRIMALDDI: platform technologies and novel anti-malarial drug targets.

Authors:  Henri Vial; Donatella Taramelli; Ian C Boulton; Steve A Ward; Christian Doerig; Kelly Chibale
Journal:  Malar J       Date:  2013-11-05       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.